The Riverside Company completed the investment in Transplant Connect.

The Riverside Company, a private equity firm, completed the investment in Transplant Connect, an operator of a cloud-based clinical platform. Financial terms were not disclosed. “Transplant Connect is an excellent addition to the expanding InVita platform as we continue to grow our areas of focus in the healthcare industry. We look forward to supporting the continued growth and innovation of Transplant Connect’s product suite and footprint," Loren Schlachet, Riverside Managing Partner.